Notice on quality defect of the batch 3055005A of Cadil 25 mg tablets and the batch 4242001B of Excita 10 mg film-coated tablets
06.02.2015
Farmal d.d., the marketing authorisation holder for Cadil 25 mg tablets and Excita 10 mg film-coated tablets has notified the Agency for Medicinal Products and Medical Devices (HALMED) on the discovered quality defect of the batch 3055005A of Cadil 25 mg and batch 4242001B of Excita 10 mg.
The concerned batches are placed on the Croatian market with an obligation to provide a written note on this quality defect to pharmacies.
More information is accessible under the link below.
more
